Search research articles
Contact Us
Filters
Showing results (1-10 of 105) with videos related to
Page
of 11
Sort By:
Cell Cycle (Georgetown, Tex.)
|
November 13, 2008
A novel MCM-2 fragment with potential biological function in senescence
Khandan Keyomarsi
Advances in Experimental Medicine and Biology
|
November 13, 2007
Cell cycle deregulation in breast cancer: insurmountable chemoresistance or Achilles' heel?
Laura Lambert, Khandan Keyomarsi
Expert Opinion on Investigational Drugs
|
April 18, 2022
PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers
Linjie Luo, Khandan Keyomarsi
Breast Cancer Research : BCR
|
August 21, 2004
Low-molecular-weight cyclin E: the missing link between biology and clinical outcome
Said Akli, Khandan Keyomarsi
Cancer Biology & Therapy
|
September 26, 2003
Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy
Said Akli, Khandan Keyomarsi
Seminars in Cancer Biology
|
July 27, 2005
Cyclin E as a prognostic and predictive marker in breast cancer
Kelly K Hunt, Khandan Keyomarsi
Cancer Research
|
January 21, 2006
Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome
Ekem T Efuet, Khandan Keyomarsi
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2004
Role of cell cycle in mediating sensitivity to radiotherapy
Timothy M Pawlik, Khandan Keyomarsi
Progress in Cell Cycle Research
|
November 5, 2003
Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents
Khandan Keyomarsi, Arthur B Pardee
Cell Cycle (Georgetown, Tex.)
|
August 5, 2008
Synchronization of the cell cycle using lovastatin
Sonia Javanmoghadam-Kamrani, Khandan Keyomarsi
Page
of 11
Search research articles
Search
Showing results (1-10 of 105) with videos related to
Sort By:
Page
of 11
Cell Cycle (Georgetown, Tex.)
|
November 13, 2008
A novel MCM-2 fragment with potential biological function in senescence
Khandan Keyomarsi
Advances in Experimental Medicine and Biology
|
November 13, 2007
Cell cycle deregulation in breast cancer: insurmountable chemoresistance or Achilles' heel?
Laura Lambert, Khandan Keyomarsi
Expert Opinion on Investigational Drugs
|
April 18, 2022
PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers
Linjie Luo, Khandan Keyomarsi
Breast Cancer Research : BCR
|
August 21, 2004
Low-molecular-weight cyclin E: the missing link between biology and clinical outcome
Said Akli, Khandan Keyomarsi
Cancer Biology & Therapy
|
September 26, 2003
Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy
Said Akli, Khandan Keyomarsi
Seminars in Cancer Biology
|
July 27, 2005
Cyclin E as a prognostic and predictive marker in breast cancer
Kelly K Hunt, Khandan Keyomarsi
Cancer Research
|
January 21, 2006
Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome
Ekem T Efuet, Khandan Keyomarsi
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2004
Role of cell cycle in mediating sensitivity to radiotherapy
Timothy M Pawlik, Khandan Keyomarsi
Progress in Cell Cycle Research
|
November 5, 2003
Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents
Khandan Keyomarsi, Arthur B Pardee
Cell Cycle (Georgetown, Tex.)
|
August 5, 2008
Synchronization of the cell cycle using lovastatin
Sonia Javanmoghadam-Kamrani, Khandan Keyomarsi
Page
of 11